Patent details

Basic Information

Publication number:

EP2024375

PCT Application Number:

PCT/US/2007/068209

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077618734

PCT Publication Number:

WO/2007/136982

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS

French Title of Invention:

INHIBITEURS DE VHC NS5B DE TYPE INDOLOBENZAZÉPINE FUSIONNÉE À UN CYCLOPROPYLE

German Title of Invention:

CYCLOPROPYL-ANNELIERTE INDOLOBENZAZEPINE ALS HCV-NS5B-INHIBITOREN

SPC Number:

Dates

Filing date:

04/05/2007

Grant date:

09/03/2011

EP Publication Date:

09/03/2011

PCT Publication Date:

29/11/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/02/2009

EP B1 Publication Date:

09/03/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/05/2020

Expiration date:

04/05/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/01/2019

 

 

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:

12/01/2015

To:

23/01/2019

Name:

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND

Address:

HINTERBERGSTRASSE 16, 6312 STEINHAUSEN, Switzerland (CH)

From:

04/05/2007

To:

11/01/2015

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543-4000, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

04/05/2011

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

HEWAWASAM Piyasena

Address:

United States (US)

2

Name:

DING Min

Address:

United States (US)

3

Name:

BENDER John A.

Address:

United States (US)

4

Name:

GENTLES Robert G.

Address:

United States (US)

Priority

1

Priority Number:

801125 P

Priority Date:

17/05/2006

Priority Country:

United States (US)

2

Priority Number:

802005 P

Priority Date:

19/05/2006

Priority Country:

United States (US)

3

Priority Number:

852084 P

Priority Date:

16/10/2006

Priority Country:

United States (US)

4

Priority Number:

894757 P

Priority Date:

14/03/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 519/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20190000045A

Date Registered:

23/01/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Address:

Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/05/2019

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
23/01/2019	Request For Change	6
23/01/2019	Outgoing Correspondence	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56